Annual Current Assets
$777.11 M
-$106.79 M-12.08%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual total current assets is $777.11 million, with the most recent change of -$106.79 million (-12.08%) on December 31, 2023.
- During the last 3 years, RARE annual current assets has fallen by -$518.19 million (-40.01%).
- RARE annual current assets is now -40.01% below its all-time high of $1.30 billion, reached on December 31, 2020.
Performance
RARE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$799.61 M
-$165.03 M-17.11%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly total current assets is $799.61 million, with the most recent change of -$165.03 million (-17.11%) on September 30, 2024.
- Over the past year, RARE quarterly current assets has increased by +$200.42 million (+33.45%).
- RARE quarterly current assets is now -38.27% below its all-time high of $1.30 billion, reached on December 31, 2020.
Performance
RARE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
RARE Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.1% | +33.5% |
| 3 y3 years | -40.0% | -5.6% |
| 5 y5 years | +48.8% | +30.3% |
RARE Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.1% | at low | -21.0% | +34.2% |
| 5 y | 5-year | -40.0% | at low | -38.3% | +34.2% |
| alltime | all time | -40.0% | +6994.9% | -38.3% | +1347.9% |
Ultragenyx Pharmaceutical Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $799.61 M(-17.1%) |
| Jun 2024 | - | $964.64 M(+61.9%) |
| Mar 2024 | - | $595.97 M(-18.6%) |
| Dec 2023 | $713.90 M(+7.9%) | $732.18 M(+22.2%) |
| Sep 2023 | - | $599.19 M(-14.7%) |
| Jun 2023 | - | $702.14 M(-8.4%) |
| Mar 2023 | - | $766.34 M(-13.3%) |
| Dec 2022 | $661.54 M(-0.6%) | $883.90 M(-12.7%) |
| Sep 2022 | - | $1.01 B(+49.2%) |
| Jun 2022 | - | $678.54 M(-4.1%) |
| Mar 2022 | - | $707.52 M(-17.4%) |
| Dec 2021 | $665.79 M(+43.4%) | $856.60 M(+1.1%) |
| Sep 2021 | - | $846.88 M(-10.8%) |
| Jun 2021 | - | $949.49 M(-11.3%) |
| Mar 2021 | - | $1.07 B(-17.3%) |
| Dec 2020 | $464.25 M(+63.2%) | $1.30 B(+48.5%) |
| Sep 2020 | - | $872.00 M(-3.8%) |
| Jun 2020 | - | $906.04 M(+1.3%) |
| Mar 2020 | - | $894.32 M(+5.1%) |
| Dec 2019 | $284.48 M(+44.3%) | $851.02 M(+38.7%) |
| Sep 2019 | - | $613.49 M(-12.3%) |
| Jun 2019 | - | $699.43 M(-11.1%) |
| Mar 2019 | - | $786.89 M(+50.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $197.19 M(-10.8%) | $522.37 M(-7.9%) |
| Sep 2018 | - | $567.48 M(-6.2%) |
| Jun 2018 | - | $604.74 M(+4.0%) |
| Mar 2018 | - | $581.58 M(+115.7%) |
| Dec 2017 | $221.17 M(+59.2%) | $269.58 M(-31.0%) |
| Sep 2017 | - | $390.90 M(-6.9%) |
| Jun 2017 | - | $419.79 M(-5.6%) |
| Mar 2017 | - | $444.69 M(+10.7%) |
| Dec 2016 | $138.93 M(+27.0%) | $401.69 M(-3.6%) |
| Sep 2016 | - | $416.79 M(+1.4%) |
| Jun 2016 | - | $411.08 M(-4.5%) |
| Mar 2016 | - | $430.23 M(-4.4%) |
| Dec 2015 | $109.36 M(+2303.0%) | $450.21 M(-2.3%) |
| Sep 2015 | - | $460.71 M(+36.9%) |
| Jun 2015 | - | $336.53 M(-4.0%) |
| Mar 2015 | - | $350.51 M(+81.2%) |
| Dec 2014 | $4.55 M(+2.9%) | $193.42 M(-6.4%) |
| Sep 2014 | - | $206.74 M(+30.7%) |
| Jun 2014 | - | $158.22 M(-6.7%) |
| Mar 2014 | - | $169.64 M(+207.2%) |
| Dec 2013 | $4.42 M(+136.5%) | $55.23 M(-17.2%) |
| Sep 2013 | - | $66.67 M(-22.9%) |
| Dec 2012 | $1.87 M(+59.1%) | $86.44 M |
| Dec 2011 | $1.18 M | - |
FAQ
- What is Ultragenyx Pharmaceutical annual total current assets?
- What is the all time high annual current assets for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual current assets year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly total current assets?
- What is the all time high quarterly current assets for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly current assets year-on-year change?
What is Ultragenyx Pharmaceutical annual total current assets?
The current annual current assets of RARE is $777.11 M
What is the all time high annual current assets for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual total current assets is $1.30 B
What is Ultragenyx Pharmaceutical annual current assets year-on-year change?
Over the past year, RARE annual total current assets has changed by -$106.79 M (-12.08%)
What is Ultragenyx Pharmaceutical quarterly total current assets?
The current quarterly current assets of RARE is $799.61 M
What is the all time high quarterly current assets for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly total current assets is $1.30 B
What is Ultragenyx Pharmaceutical quarterly current assets year-on-year change?
Over the past year, RARE quarterly total current assets has changed by +$200.42 M (+33.45%)